Back to RHUMBLINE ADVISERS RHUMBLINE ADVISERS

GYREGYRE
9 quarters

Position history for RHUMBLINE ADVISERSRHUMBLINE ADVISERS's holdings in GYRE THERAPEUTICS INC

RHUMBLINE ADVISERS holds 16,865 shares of GYRE (GYRE THERAPEUTICS INC), worth $111,131 as of 2026-Q2. The position was increased (+28.6% shares). GYRE represents 0.0% of RHUMBLINE ADVISERS's portfolio.

Current Value

$111,131

Current Shares

16,865

Total Value Change

-$11,635

Total Shares Change

+6,574

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
16,865
+28.6%
$111,1310.0%$6.59
27
2026-Q1
Decreased
13,116
-6.5%
$91,4100.0%$7.90
0
2025-Q4
Increased
14,032
+4.5%
$99,0570.0%$7.02
23
2025-Q3
Decreased
13,432
-17.0%
$100,1960.0%$7.50
0
2025-Q2
Increased
16,186
+45.3%
$118,9590.0%$7.42
30
2025-Q1
Increased
11,141
+6.8%
$86,0010.0%$9.11
23
2024-Q4
Increased
10,432
+0.1%
$126,2220.0%$12.66
22
2024-Q3
Increased
10,424
+1.3%
$130,7080.0%$12.76
22
2024-Q2
New
10,291
-
$122,7660.0%$11.93
31

Other major holders of GYRE: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used